Dose-response relationships of cytotoxicity, PFC response and histology in the spleen in rats treated with alkylating agents

Toxicology

Volumn 107, Issue 1, 1996, Pages 47-60

  Doi, Takayoshi ^a   Nagai, Hirofumi ^a   Tsukuda, Ryoichi ^a   Suzuki, Tsuyoshi ^a  

^a TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

Chlorambucil; Cyclophosphamide; Histology; Immunotoxicity; Melphalan; Nitromin; Rats; Spleen

Indexed keywords

ALKYLATING AGENT; CHLORAMBUCIL; CHLORMETHINE N OXIDE; CYCLOPHOSPHAMIDE; MELPHALAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; HISTOLOGY; IMMUNOTOXICITY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PLAQUE FORMING CELL; PRIORITY JOURNAL; RAT; SPLEEN WEIGHT;

ANIMALIA;

EID: 0030026471     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0300-483X(95)03200-Y     Document Type: Article

References (51)

1. Aiko, I., Owari, S. and Torigoe, M. (1952) Nitrogen mustard N-oxide and its effect on the Yoshida sarcoma. J. Pharm. Soc. (Japan) 72, 1297-1300.
2. Asai, J., Koshikawa, T. and Iijima, S. (1979) Studies on cellular responses in the perifollicular zone of rat spleen. Recent Adv. REC Res. 19, 54-75.
3. Braun, D.P. and Harris, J.E. (1981) Modulation of the immune response by chemotherapy. Pharmacol. Ther. 14, 89-122.
4. Brown, I.N. and Berenbaum, M.C. (1964) Inhibition of immune processes by 'melphalan'. Nature 201, 1340.
5. Calabresi, P. and Chabner, B.A. (1990) Chemotherapy of neoplastic diseases. In: A.G. Gilman, T.W. Rail, A.S. Nies and P. Tayler (Eds), Goodman and Gilman's Pharmacological Basis of Therapeutics (8th Ed.), Pergamon Press, New York, pp. 1202-1276.
6. Cunningham, A.J. and Szenberg, A. (1968) Further improvements in the plaque technique for detecting single antibody-forming cells. Immunology 14, 599-601.
7. Dean, J.H. and Thurmond, L.M. (1987) Immunotoxicology: an overview. Toxicol. Pathol. 15, 265-271.
8. Descotes, J. (Ed) (1988) Immunotoxicity of immunodepressive and immunoenhancing drugs. In: Immunotoxicology of Drugs and Chemicals, Elsevier, Amsterdam, pp. 234-236.
9. Descotes, J. (1992) Immunosuppression: Current strategies. J. Toxicol. Clin. Exp. 12, 421-427.
10. Descotes, J., Vial, T. and Verdier, F. (1993) The how, why and when of immunological testing. Comp. Haematol. 3, 63-66.
11. Doi, T., Nakai, Y., Yamamoto, M. and Ando, T. (1992) Appropriate conditions for the plaque-forming cell (PFC) assay in rats and effects of cyclophosphamide on PFC response. J. Toxicol. Sci. (Japan) 17, 225-233.
12. Exon, J.H., Koller, L.D., Talcott, P.A., O'Reilly, C.A. and Henningsen, G.M. (1986) Immunotoxicity testing: an economical multiple-assay approach. Fundam. Appl. Toxicol. 7, 387-397.
13. Fautz, R. and Miltenburger, H.G. (1993) Immunotoxicity screening in vitro using an economical multiple endpoint approach. Toxicol. In Vitro 7, 305-310.
14. Fouhil, A.F.I.E., Iskander, F.A. and Turkall, R.M. (1993) Effect of alternate-day hydrocortisone therapy on the immunologically immature rat. II: Changes in T- and B-cell area in spleen. Toxicol. Pathol. 21, 383-390.
15. Goldschneider, I. and McGregor, D.D. (1973) Anatomical distribution of T and B lymphocytes in rat. Development of lymphocyte-specific antisera. J. Exp. Med. 138, 1443-1465.
16. Greaves, P. and Faccini, J.M. (1992) Haemopoietic and lymphatic systems. In: Rat Histopathology, A Glossary for Use in Toxicity and Carcinogenicity Studies, Elsevier, Amsterdam, pp. 43-66.
17. Haskell, C.M. (1977) Immunologic aspects of cancer chemotherapy. Ann. Rev. Pharmacol. Toxicol. 17, 179-195.
18. Heppner, G.H. and Calabresi, P. (1976) Selective suppression of humoral immunity by antineoplastic drugs. Ann. Rev. Pharmacol. Toxicol. 16, 367-379.
19. Imamura, H., Ikegami, K. and Takeuchi, M. (1975) Comparative studies of methansulfonic acid esters and other antitumor agents on immune response. Yakugaku Zasshi (Japan) 95, 453-459.
20. Kempf, R.A. and Mitchell, M.S. (1984) Effects of chemotherapeutic agents on the immune response. I. Cancer Invest. 2, 459-466.
21. Kempf, R.A. and Mitchell, M.S. (1985) Effects of chemotherapeutic agents on the immune response. II. Cancer Invest. 3, 23-33.
22. Kim, Z. (1981) Immunosuppression and chemotherapeutic agents. Ann. Allergy 47, 78-83.
23. Kociba, R.J. (1981) Morphologic considerations in the detection of immune suppression in routine toxicity studies. In: R.P. Sharma (Ed), Immunologic Considerations in Toxicology (Chapter 6), CRC Press, Inc., Florida, pp. 123-131.
24. van Krieken, J.H.J.M. and te Velde, J. (1992) Spleen. In: S.S. Sternberg (Ed), Histology for Pathologists, Raven Press, New York, pp. 253-260.
25. Kumararatne, D.S. Bazin, H. and MacLennan, I.C.M. (1981) Marginal zones: the major B cell compartment of rat spleens. Eur. J. Immunol. 11, 858-864.
26. Lin, H. (1973) Differential lethal effect of cytotoxic agents on proliferating and nonproliferating lymphoid cells. Cancer Res. 33, 1716-1720.
27. Lin, H. (1976) Schedule-dependent effect of phase-specific cytotoxic agents on production of hemolytic plaque-forming cells. J. Natl. Cancer Inst. 56, 95-99.
28. Luster, M.I., Munson, A.E., Thomas, P.T., Holsapple, M.P., Fenters, J.D., White, Jr, K.L., Lauer, L.D., Germolec, D.R., Rosenthal, G.J. and Dean, J.H. (1988) Methods evaluation. Development of a testing battery to assess chemical-induced immunotoxicity: National Toxicology Program's guidelines for immunotoxicity evaluation in mice. Fundam. Appl. Toxicol. 10, 2-19.
29. Luster, M.I., Portier, C., Pait, D.G., White, Jr, K.L. Gennings, C., Munson, A.E. and Rosenthal, G.J. (1992) Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests. Fundam. Appl. Toxicol. 18, 200-210.
30. Luster, M.I, Portier, C., Pait, D.G., Rosenthal, G.J., Germolec, D.R., Corsini, E. Blaylock, B.L., Pollock, P., Kouchi, Y., Craig, W., White, Jr, K.L., Munson, A.E. and Comment, C.E. (1993) Risk assessment in immunotoxicology. II. Relationships between immune and host resistance tests. Fundam. Appl. Toxicol. 21, 71-82.
31. Makinodan, T., Santos, G.W. and Quinn, B.P. (1970) Immunosuppressive drugs. Pharmacol. Rev. 22, 189-247.
32. Matsumoto, K., Sekita, K., Ochiai, T., Takagi, A., Takada, K., Furuya, T., Kurokawa, Y., Saito, Y., Tesima, R., Suzuki, K., Sawada, J., Terao, T. and Tobe, M. (1990) Evaluation of immunotoxicity testings using azathioprine-treated rats: the international collaborative immunotoxicity study (azathioprine). Bull. Natl. Inst. Hyg. Sci. (Japan) 108, 34-39.
33. Miller, K. (1985) Review: Immunotoxicology. Clin. Exp. Immunol. 61, 219-223.
34. Miller, K. (1992) In vitro immunotoxicology. J. Toxicol. Clin. Exp. 12, 455-460.
35. Munson, A.E. and White, Jr, K.L. (1990) Immunotoxicology. In: D.B. Clayson, I.C. Munro, P. Shubik and J.A. Swenberg (Eds), Progress in Predictive Toxicology, Elsevier, Amsterdam, pp. 285-313.
36. Ophir, R., Pecht, M., Rashid, G., Halperin, D., Lourie, S., Burstein, Y., Ben-Efraim, S. and Trainin, N. (1990) A synthetic thymic hormone, THF-γ2, repairs immunodeficiency of mice cured of plasmacytoma by melphalan. Int. J. Cancer 45, 1190-1194.
37. Remandet, B. (1992) Immunotoxicology and conventional toxicology. J. Toxicol. Clin. Exp. 12, 397-403.
38. Riganti, F., Sironi, M., Kankova, M., D'Incalci, M., Spreafico, F., Mantovani, A. and Vecchi, A. (1992) The unique interaction with immunity of FCE 24517, an antitumor drug with a novel mode of action. Int. J. Immunopharmacol. 14, 239-251.
39. Santos, G.W., Owens, Jr, A.H. and Sensenbrenner, L.L. (1964) Effects of selected cytotoxic agents on antibody production in man: A preliminary report. Ann. NY. Acad. Sci. 114, 404-423.
40. Santos, G.W. (1967) Immunosuppressive drugs. I. Fed. Proc. 26, 907-913.
41. Schuurman, H.-J., Krajnc-Franken, M.A.M., Kuper, C.F., van Loveren, H. and Vos. J.G. (1991) Immune system. In: W.M. Haschek and C.G. Rousseaux (Eds), Handbook of Toxicologic Pathology, Academic Press, San Diego, pp. 421-487.
42. Schuurman, H.-J., Kuper, C.F. and Vos, J.G. (1994) Histopathology of the immune system as a tool to assess immunotoxicity. Toxicology 86, 187-212.
43. Stockman, G.D., Heim, L.R., South, M.A. and Trentin, J.J. (1973) Differential effects of cyclophosphamide on the B and T cell compartments of adult mice. J. Immunol. 110, 277-282.
44. Turk, J.L. and Poulter, L.W. (1972) Selective depletion of lymphoid tissue by cyclophosphamide. Clin. Exp. Immunol. 10, 285-296.
45. Turk, J.L. and Parker, D. (1982) Effect of cyclophosphamide on immunological control mechanisms. Immunol. Rev. 65, 99-113.
46. Uyeki, E.M. and Long, J. (1967) Antitumor agents on the production of primary and secondary spleen hemolysin plaque-forming cells. J. Pharmacol. Exp. Ther. 158, 365-371.
47. Uyeki, E.M. (1967) Effects of several antitumour agents on spleen hemolysin plaque-forming cells. Biochem. Pharmacol. 16, 53-58.
48. Verdier, F. (1992) Specific methods to evaluate the immune system. Functional assays. J. Toxicol. Clin. Exp. 12, 405-419.
49. Vos, J.G. (1977) Immune suppression as related to toxicology CRC Crit. Rev. Toxicol. 5, 67-101.
50. Vos, J.G. and van Loveren, H. (1987) Immunotoxicity testing in the rat. Adv. Mod. Environ. Toxicol. 13, 167-180.
51. Winkelstein, A. (1984) Immune suppression resulting from various cytotoxic agents. Clin. Immunol. Allergy 4, 295-315.